ANI Net Profit Margin from 2010 to 2025

ANIP Stock  USD 61.89  7.31  13.39%   
ANI Pharmaceuticals Net Loss yearly trend continues to be relatively stable with very little volatility. Net Loss is likely to drop to -0.03. Net Loss is the percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(0.03)
Current Value
(0.03)
Quarterly Volatility
29.70522794
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ANI Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ANI Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 72.2 M, Interest Expense of 32.5 M or Selling General Administrative of 181.6 M, as well as many indicators such as Price To Sales Ratio of 1.65, Dividend Yield of 0.0012 or PTB Ratio of 5.23. ANI financial statements analysis is a perfect complement when working with ANI Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of ANI Pharmaceuticals Correlation against competitors.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

Latest ANI Pharmaceuticals' Net Profit Margin Growth Pattern

Below is the plot of the Net Profit Margin of ANI Pharmaceuticals over the last few years. It is the percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue. ANI Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ANI Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Profit Margin10 Years Trend
Slightly volatile
   Net Profit Margin   
       Timeline  

ANI Net Profit Margin Regression Statistics

Arithmetic Mean(9.49)
Coefficient Of Variation(312.94)
Mean Deviation15.47
Median(0.01)
Standard Deviation29.71
Sample Variance882.40
Range119
R-Value0.47
Mean Square Error737.42
R-Squared0.22
Significance0.07
Slope2.93
Total Sum of Squares13,236

ANI Net Profit Margin History

2025 -0.0317
2024 -0.0301
2023 0.0386
2022 -0.15
2021 -0.2
2020 -0.11
2019 0.0295

About ANI Pharmaceuticals Financial Statements

ANI Pharmaceuticals shareholders use historical fundamental indicators, such as Net Profit Margin, to determine how well the company is positioned to perform in the future. Although ANI Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in ANI Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on ANI Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(0.03)(0.03)

Additional Tools for ANI Stock Analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.